Medivation Prostate Therapeutics competitive analysis

Loading summary...

Explore Medivation Prostate Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 30, 2025
Patent NumberGrant DateTitleTotal Oppositions
Aug 18, 2021Formulations Of Enzalutamide12
Aug 22, 2018Treatment Of Breast Cancer1

Latest publications and patents of Medivation Prostate Therapeutics New

Explore the latest publications and patents granted to Medivation Prostate Therapeutics, showcasing their recent innovations and technological advancements.

Last updated on: Oct 24, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Medivation Prostate Therapeutics

Aug 18, 2021Formulations Of EnzalutamideGranted And Under Opposition
Aug 22, 2018Treatment Of Breast CancerOpposition Rejected

Latest PTAB cases involving Medivation Prostate Therapeutics

Discover the latest PTAB cases involving Medivation Prostate Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Medivation Prostate Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 30, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MEDIVATION PROSTATE THERAPEUTICS - 13 - -
ALFRED E TIEFENBACHER443 - -
BULLE DR19 - - -
HAMM & WITTKOPP112 - - -